DanCann Pharma A/S 

0
110
+€0.00+0% 00:00 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

即將到來

財報

9月25日預期
Q4 2025
Q2 2026
999
333
-333
-999
預期EPS
不適用
實際EPS
不適用

財務

6.01%利潤率
有盈利
2020
2021
2022
2023
2024
2025
3.83B營收
230.39M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 DAN.STU 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Danieli & C. Officine Meccaniche S.p.A., established in Buttrio, Italy, in 1914, specializes in the engineering, construction, and distribution of industrial plants for the global iron and steel sector. Its operational footprint spans Europe, Russia, the Middle East, the Americas, and Southeast Asia. The company is organized into two primary divisions: Plant Making and Steel Making. The Plant Making division provides a comprehensive range of equipment and solutions that cover the entire steel production process. This includes facilities for raw material processing such as mines, pellet production plants, and scrap shredders; primary steelmaking units like blast furnaces, direct reduction plants, and steelworks for producing liquid steel; and continuous casting machines for blooms, billets, slabs, and thin slabs. Furthermore, this segment delivers rolling mills for long products, seamless and welded tubes, and both hot and cold flat products, alongside specialized process lines for flat materials, dimensional checking systems, non-destructive quality control setups, and conditioning plants. The offerings also extend to secondary processing machinery—including peeling, straightening, two-roll reeling, and drawing machines—as well as forging presses, manipulators, and complete forging plants. It also supplies extrusion presses for ferrous and non-ferrous materials, longitudinal and transversal cutting plants, advanced plant automation systems, and various cranes and lifting apparatus. Through its Steel Making segment, Danieli engages in the manufacturing and sale of specialized steel products. This encompasses special steels offered as ingots, blooms, billets, and both forged and rolled products. Additionally, the company produces structural steels, including high carbon, case-hardened, hardened and tempered, and surface-hardened varieties, all essential for diverse engineering applications.
顯示更多
執行長
Giacomo Mareschi Danieli
員工
10088
國家
義大利
ISIN
DK0061410487
WKN
000A412SL

上市

0 則留言

分享你的想法

常見問題

DanCann Pharma A/S 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Boerse Stuttgart 交易所,DanCann Pharma A/S 的股票以代號 DAN.STU 進行交易。
DanCann Pharma A/S 下一次財報日期是什麼時候?▼
DanCann Pharma A/S 將於 2027年3月11日 公布下一次財報。
DanCann Pharma A/S 去年的營收是多少?▼
DanCann Pharma A/S 去年的營收為 3.83BEUR。
DanCann Pharma A/S 去年的淨利是多少?▼
DAN.STU 去年的淨收益為 230.39MEUR。
DanCann Pharma A/S 有多少名員工?▼
截至 2026年11月7日,公司共有 10,088 名員工。
DanCann Pharma A/S 位於哪個產業?▼
DanCann Pharma A/S從事於Manufacturing產業。
DanCann Pharma A/S 何時完成拆股?▼
DanCann Pharma A/S 上次拆股發生於 2025年2月24日,比例為 1:1000。
DanCann Pharma A/S 的總部在哪裡?▼
DanCann Pharma A/S 的總部位於 義大利 的 Buttrio。